Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) Net Cash Flow (2020 - 2026)

Longeveron (LGVN) posted quarterly Net Cash Flow of $11.1 million for Q1 2026, up 326.24% year-over-year from $2.6 million in Q1 2025, and up 342.13% quarter-over-quarter from -$4.6 million in Q4 2025.

Longeveron (LGVN) Net Cash Flow (2020 - 2026) Analysis & Trends

Longeveron's Net Cash Flow history runs 7 years deep, the most recent figure standing at $11.1 million for Q1 2026.

  • In Q1 2026, Net Cash Flow rose 326.24% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $1.4 million (down 88.45% YoY), while the FY2025 annual figure was -$14.6 million, down 202.02% from the prior year.
  • Net Cash Flow for Q1 2026 stood at $11.1 million, up from -$4.6 million in the prior quarter.
  • The five-year high for Net Cash Flow was $11.1 million in Q1 2026, with the low at -$6.6 million in Q3 2022.
  • The 5-year median for Net Cash Flow is -$3.0 million (2024), against an average of -$582352.9.
  • Peak annual rise in Net Cash Flow reached 1433.72% in 2024, while the deepest fall reached 218.91% in 2024.
  • Longeveron's Net Cash Flow stood at -$3.1 million in 2022, then soared by 197.1% to $3.0 million in 2023, then sank by 218.91% to -$3.5 million in 2024, then slipped by 29.24% to -$4.6 million in 2025, then surged by 342.13% to $11.1 million in 2026.
  • Business Quant data shows LGVN's Net Cash Flow at $11.1 million in Q1 2026, -$4.6 million in Q4 2025, and -$1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -183.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 407.41 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -496,000.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -2.83 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -37.14 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 225.59 Mn
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 -5.68 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.68 Mn
Jun 30, 2026 -5.68 Mn
Mar 31, 2026 11.10 Mn
Mar 31, 2026 11.10 Mn
Dec 31, 2025 -4.58 Mn
Dec 31, 2025 -4.58 Mn
Sep 30, 2025 -1.09 Mn
Sep 30, 2025 -1.09 Mn
Jun 30, 2025 -3.99 Mn
Jun 30, 2025 -3.99 Mn
Mar 31, 2025 -4.91 Mn
Mar 31, 2025 -4.91 Mn
Dec 31, 2024 -3.55 Mn
Dec 31, 2024 -3.55 Mn
Sep 30, 2024 10.40 Mn
Sep 30, 2024 10.40 Mn
Jun 30, 2024 10.44 Mn
Jun 30, 2024 10.44 Mn
Mar 31, 2024 -3.01 Mn
Mar 31, 2024 -3.01 Mn